Gastrointestinal Drug Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 weeks by ordering today
Gastrointestinal Drug Market Trends and Forecast
The future of the gastrointestinal drug market looks promising with opportunities in the cure of gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome disorders/applications. The global gastrointestinal drug market is expected to grow with a CAGR of 4%-6% from 2022 to 2027. The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the old age people, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products.
A total of 90 figures / charts and 70 tables are provided in this 180-page report to help in your business decisions. A sample figure with insights is shown below. To learn the scope of benefits, companies researched, and other details of the gastrointestinal drug market report, please download the report brochure.
Gastrointestinal Drug Market by Segment
The study includes a forecast for the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region as follows:
Gastrointestinal Drug Market by Drug Class Type [Value ($M) shipment analysis for 2016 – 2027]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gastrointestinal drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gastrointestinal drug companies profiled in this report include.
Q1. What is the gastrointestinal drug market size?
Answer:The global gastrointestinal drug market is expected to reach an estimated $XX billion by 2027
Q2. What is the growth forecast for gastrointestinal drug market?
Answer:The gastrointestinal drug market is expected to grow at a CAGR of 4% to6% from 2022 to 2027.
Q3. What are the major drivers influencing the growth of the gastrointestinal drug market?
Answer: The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the old age people, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products..
Q4. What are the major applications or end use industries for gastrointestinal drug?
Answer:Major applications include gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome.
Q5. Who are the key gastrointestinal drug companies?
Answer:Some of the key gastrointestinal drug companies are as follows:
Answer: Lucintel forecasts that acid neutralizers will remain the largest segment and witness highest growth due to increasing consumption of antacid by growing geriatric population that are suffering from Gastroesophageal Reflux Disease (GERD), higher incidences of acidity due to unhealthy lifestyle, and side effects of non-steroidal drugs and anti-inflammatory drugs.
Q7: In gastrointestinal drug market, which region is expected to be the largest in next 5 years?
Answer:North America is expected to remain the largest region and witness the highest growth over next 5 years
Q8. Do we receive customization in this report?
Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1 What are some of the most promising potential, high growth opportunities for the global gastrointestinal drug market by drug class (acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics, others (antispasmodic), route of administration (oral, intravenous, rectal), application (gastro-esophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are the changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities have taken place in the last 5 years in this market?
For any questions related to gastrointestinal drug market or related to gastrointestinal drug companies, gastrointestinal drug market share, gastrointestinal drug market analysis, gastrointestinal drug market size, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Gastrointestinal Drug Market Trends and Forecast
The future of the gastrointestinal drug market looks promising with opportunities in the cure of gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome disorders/applications. The global gastrointestinal drug market is expected to grow with a CAGR of 4%-6% from 2022 to 2027. The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the old age people, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products.
A total of 90 figures / charts and 70 tables are provided in this 180-page report to help in your business decisions. A sample figure with insights is shown below. To learn the scope of benefits, companies researched, and other details of the gastrointestinal drug market report, please download the report brochure.
Gastrointestinal Drug Market by Segment
The study includes a forecast for the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region as follows:
Gastrointestinal Drug Market by Drug Class Type [Value ($M) shipment analysis for 2016 – 2027]:
- Acid Neutralizers
- Antidiarrheal and Laxatives
- Antiemetic and Antinauseants
- Anti-inflammatory Drugs
- Biologics
- Others (Antispasmodic etc.)
- Oral
- Intravenous
- Rectal
- Gastro-esophageal Reflux Disease
- Inflammatory Bowel Disease
- Irritable Bowel Syndrome
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Asia Pacific
- China
- Japan
- India
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gastrointestinal drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gastrointestinal drug companies profiled in this report include.
- Takeda Pharmaceuticals
- Novo Nordisk A/S
- AstraZeneca Plc
- Johnson & Johnson
- AbbVie Inc. (Allergan Plc)
- Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.)
- Bayer AG
- Boehringer Ingelheim GmbH
- GlaxoSmithKline Plc.
- Lucintel forecasts within the global gastrointestinal drug market, the acid neutralizers will remain the largest segment and witness highest growth due to increasing consumption of antacid by growing geriatric population that are suffering from Gastroesophageal Reflux Disease (GERD), higher incidences of acidity due to unhealthy lifestyle, and side-effects of non-steroidal drugs and anti-inflammatory drugs.
- North America is expected to remain the largest market due to large number of geriatric population, lifestyles and eating habits (fast food eating), and increasing lifestyle diseases in North America region.
- Market Size Estimates: Gastrointestinal Drug market size estimation in terms of value ($M)
- Trend and Forecast Analysis: Market trends (2016-2021) and forecast (2022-2027) by various segments and regions.
- Segmentation Analysis: Market size by drug class, route of administration, application, and distribution channel.
- Regional Analysis: Gastrointestinal Drug market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different co-catalyst type, application, and regions for the gastrointestinal drug market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the gastrointestinal drug market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the gastrointestinal drug market size?
Answer:The global gastrointestinal drug market is expected to reach an estimated $XX billion by 2027
Q2. What is the growth forecast for gastrointestinal drug market?
Answer:The gastrointestinal drug market is expected to grow at a CAGR of 4% to6% from 2022 to 2027.
Q3. What are the major drivers influencing the growth of the gastrointestinal drug market?
Answer: The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the old age people, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products..
Q4. What are the major applications or end use industries for gastrointestinal drug?
Answer:Major applications include gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome.
Q5. Who are the key gastrointestinal drug companies?
Answer:Some of the key gastrointestinal drug companies are as follows:
- Takeda Pharmaceuticals
- Novo Nordisk A/S
- AstraZeneca Plc
- Johnson & Johnson
- AbbVie Inc. (Allergan Plc)
- Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
- Bayer AG
- Boehringer Ingelheim GmbH
- GlaxoSmithKline Plc.
Answer: Lucintel forecasts that acid neutralizers will remain the largest segment and witness highest growth due to increasing consumption of antacid by growing geriatric population that are suffering from Gastroesophageal Reflux Disease (GERD), higher incidences of acidity due to unhealthy lifestyle, and side effects of non-steroidal drugs and anti-inflammatory drugs.
Q7: In gastrointestinal drug market, which region is expected to be the largest in next 5 years?
Answer:North America is expected to remain the largest region and witness the highest growth over next 5 years
Q8. Do we receive customization in this report?
Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1 What are some of the most promising potential, high growth opportunities for the global gastrointestinal drug market by drug class (acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics, others (antispasmodic), route of administration (oral, intravenous, rectal), application (gastro-esophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are the changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities have taken place in the last 5 years in this market?
For any questions related to gastrointestinal drug market or related to gastrointestinal drug companies, gastrointestinal drug market share, gastrointestinal drug market analysis, gastrointestinal drug market size, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2016 TO 2027
3.1: Macroeconomic Trends (2016-2021) and Forecast (2022-2027)
3.2: Global Gastrointestinal Drug Market Trends (2016-2021) and Forecast (2022-2027)
3.3: Global Gastrointestinal Drug Market by Drug Class
3.3.1: Acid Neutralizers
3.3.2: Antidiarrheal and Laxatives
3.3.3: Antiemetic and Antinauseants
3.3.4: Anti-inflammatory Drugs
3.3.5: Biologics
3.3.6: Others (Antispasmodic etc.)
3.4: Global Gastrointestinal Drug Market by Route of Administration
3.4.1: Oral
3.4.2: Intravenous
3.4.3: Rectal
3.5: Global Gastrointestinal Drug Market by Application/Disorder Type
3.5.1: Gastro-esophageal Reflux Disease
3.5.2: Inflammatory Bowel Disease
3.5.3: Irritable Bowel Syndrome
3.6: Global Gastrointestinal Drug Market by Distribution Channel
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2016 TO 2027
4.1: Global Gastrointestinal Drug Market by Region
4.2: North American Gastrointestinal Drug Market
4.2.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.2.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.2.3: United States Gastrointestinal Drug Market
4.2.4: Canadian Gastrointestinal Drug Market
4.2.5: Mexican Gastrointestinal Drug Market
4.3: European Gastrointestinal Drug Market
4.3.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.3.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.3.3: German Gastrointestinal Drug Market
4.3.4: French Gastrointestinal Drug Market
4.3.5: The United kingdom Gastrointestinal Drug Market
4.4: APAC Gastrointestinal Drug Market
4.4.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.4.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.4.3: Chinese Gastrointestinal Drug Market
4.4.4: Japanese Gastrointestinal Drug Market
4.4.5: Indian Gastrointestinal Drug Market
4.5: ROW Gastrointestinal Drug Market
4.5.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.5.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Geographical Reach
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Gastrointestinal Drug Market by Application Type
6.1.2: Growth Opportunities for the Global Gastrointestinal Drug Market by Co-Catalyst Type
6.1.3: Growth Opportunities for the Global Gastrointestinal Drug Market by Region
6.2: Emerging Trends in the Global Gastrointestinal Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Gastrointestinal Drug Market
6.3.3: Mergers and Acquisitions, and Joint Ventures in the Global Gastrointestinal Drug Industry
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Takeda Pharmaceuticals
7.2: Novo Nordisk A/S
7.3: AstraZeneca Plc
7.4: Johnson & Johnson
7.5: AbbVie Inc.(Allergan Plc)
7.6: Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
7.7: Bayer AG
7.8: Boehringer Ingelheim GmbH
7.9: GlaxoSmithKline Plc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2016 TO 2027
3.1: Macroeconomic Trends (2016-2021) and Forecast (2022-2027)
3.2: Global Gastrointestinal Drug Market Trends (2016-2021) and Forecast (2022-2027)
3.3: Global Gastrointestinal Drug Market by Drug Class
3.3.1: Acid Neutralizers
3.3.2: Antidiarrheal and Laxatives
3.3.3: Antiemetic and Antinauseants
3.3.4: Anti-inflammatory Drugs
3.3.5: Biologics
3.3.6: Others (Antispasmodic etc.)
3.4: Global Gastrointestinal Drug Market by Route of Administration
3.4.1: Oral
3.4.2: Intravenous
3.4.3: Rectal
3.5: Global Gastrointestinal Drug Market by Application/Disorder Type
3.5.1: Gastro-esophageal Reflux Disease
3.5.2: Inflammatory Bowel Disease
3.5.3: Irritable Bowel Syndrome
3.6: Global Gastrointestinal Drug Market by Distribution Channel
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2016 TO 2027
4.1: Global Gastrointestinal Drug Market by Region
4.2: North American Gastrointestinal Drug Market
4.2.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.2.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.2.3: United States Gastrointestinal Drug Market
4.2.4: Canadian Gastrointestinal Drug Market
4.2.5: Mexican Gastrointestinal Drug Market
4.3: European Gastrointestinal Drug Market
4.3.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.3.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.3.3: German Gastrointestinal Drug Market
4.3.4: French Gastrointestinal Drug Market
4.3.5: The United kingdom Gastrointestinal Drug Market
4.4: APAC Gastrointestinal Drug Market
4.4.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.4.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
4.4.3: Chinese Gastrointestinal Drug Market
4.4.4: Japanese Gastrointestinal Drug Market
4.4.5: Indian Gastrointestinal Drug Market
4.5: ROW Gastrointestinal Drug Market
4.5.1: Market by Application: Gastro-Esophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome
4.5.2: Market by Drug Class: Acid Neutralizers, Antidiarrheal And Laxatives, Antiemetic And Antinauseants, Anti-Inflammatory Drugs, Biologics, Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Geographical Reach
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Gastrointestinal Drug Market by Application Type
6.1.2: Growth Opportunities for the Global Gastrointestinal Drug Market by Co-Catalyst Type
6.1.3: Growth Opportunities for the Global Gastrointestinal Drug Market by Region
6.2: Emerging Trends in the Global Gastrointestinal Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Gastrointestinal Drug Market
6.3.3: Mergers and Acquisitions, and Joint Ventures in the Global Gastrointestinal Drug Industry
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Takeda Pharmaceuticals
7.2: Novo Nordisk A/S
7.3: AstraZeneca Plc
7.4: Johnson & Johnson
7.5: AbbVie Inc.(Allergan Plc)
7.6: Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
7.7: Bayer AG
7.8: Boehringer Ingelheim GmbH
7.9: GlaxoSmithKline Plc.
